Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain

B Schilter and CJ Omiecinski

Department of Environmental Health, School of Public Health and Community Medicine, University of Washington, Seattle 98195.

In the present study, we developed a very sensitive, semiquantitative assay based on the reverse transcriptase-coupled polymerase chain reaction to measure, in a region-selective manner, mRNA expression patterns within the brain for microsomal epoxide hydrolase and several cytochrome P-450s (P-450s) known to be induced by prototypic agents in other tissues. The P-450s assessed included the polyaromatic hydrocarbon-inducible CYP1A1 and CYP1A2 systems, together with the phenobarbital-inducible P-450s, CYP2B1, CYP2B2, CYP3A1, which were examined 18 hr after a single intraperitoneal dose of the respective inducing agents. Highly region-specific patterns of expression were evident for P-450 mRNAs within the rat brain. In the control, uninduced brain, CYP1A1 mRNAs were readily detected in the striatum and in the hypothalamus, and to a lesser extent in the other regions examined. The regional pattern of expression was similar for CYP1A2; however, a major difference was noted in the olfactory bulbs, characterized by a relatively high level of CYP1A2 mRNA but correspondingly low levels of CYP1A1. Within the brain regions examined, the highest content of CYP2B1 and CYP2B2 mRNAs were present in the striatum and in the cerebellum, whereas CYP3A1 levels varied only slightly across the respective regions. In contrast to the P-450s, microsomal epoxide hydrolase mRNAs were expressed at relative homogeneous amounts throughout the brain. beta-Naphthoflavone markedly increased the CYP1A1 and CYP1A2 mRNA contents of each brain region investigated, although this agent did not affect levels of epoxide hydrolase. At 18 hr post- treatment with phenobarbital, an optimal time period for hepatic induction, brain expression was characterized by a complex pattern of effects, with increased levels noted for CYP2B1 mRNA content in the medulla oblongata, midbrain, and cortex, but decreased contents measured in the cerebellum, the hypothalamus, and the striatum. In each of these respective regions, CYP2B2 content was profoundly decreased whereas epoxide hydrolase expression was slightly increased by the same treatment. These results establish that the central nervous system actively expresses a number of different biotransformation gene products in a regional specific and inducer-dependent manner, and suggest that for tissues exhibiting low regenerative capacity, like the brain, such reactions are likely to be of critical toxicological significance.

Volume 44, Issue 5, pp. 990-996, 11/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Johri, A. Dhawan, R. L. Singh, and D. Parmar Persistence in Alterations in the Ontogeny of Cerebral and Hepatic Cytochrome P450s following Prenatal Exposure to Low Doses of Lindane Toxicol. Sci., February 1, 2008; 101(2): 331 - 340. [Abstract] [Full Text] [PDF]

				L. Granberg, A. Ostergren, I. Brandt, and E. B. Brittebo CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells Drug Metab. Dispos., March 1, 2003; 31(3): 259 - 265. [Abstract] [Full Text] [PDF]

				R. P. Meyer, M. Podvinec, and U. A. Meyer Cytochrome P450 CYP1A1 Accumulates in the Cytosol of Kidney and Brain and Is Activated by Heme Mol. Pharmacol., November 1, 2002; 62(5): 1061 - 1067. [Abstract] [Full Text] [PDF]

				R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]

				B. Schilter, M. R. Andersen, C. Acharya, and C. J. Omiecinski Activation of Cytochrome P450 Gene Expression in the Rat Brain by Phenobarbital-Like Inducers J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 916 - 922. [Abstract] [Full Text]

				W. Kozak, M. J. Kluger, A. Kozak, M. Wachulec, and K. Dokladny Role of cytochrome P-450 in endogenous antipyresis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R455 - R460. [Abstract] [Full Text] [PDF]

				S. Campbell, F Carlotti, P. Hall, A. Clark, and C. Wolf Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation J. Cell Sci., January 11, 1996; 109(11): 2619 - 2625. [Abstract] [PDF]